[1] WANG Z, PALADE V. Building interpretable fuzzy models for high dimensional data analysis in cancer diagnosis[J]. BMC Genomics, 2011, 12(Suppl 2): S5. [2] CHEN H, ZHAO H, SHEN J, et al. Supervised machine learning model for high dimensional gene data in colon cancer detection[C]// 2015 IEEE International Congress on Big Data. IEEE, 2015: 134-141. [3] GOLUB T R, SLONIM D K, TAMAYO P, et al. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring[J]. Science, 1999, 286(5439): 531-537. [4] HONG J H, CHO S B. Gene boosting for cancer classification based on gene expression profiles[J]. Pattern Recognition, 2009, 42(9): 1761-1767. [5] ALON U, BARKAI N, NOTTERMAN D A, et al. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays[J]. Proceedings of the National Academy of Sciences, 1999, 96(12): 6745-6750. [6] TAN A C, GILBERT D. Ensemble machine learning on gene expression data for cancer classification[J]. Applied Bioinformatics, 2003, 2(3 Suppl): S75-83. [7] LIN W J, CHEN J J. Class-imbalanced classifiers for high-dimensional data[J]. Briefings in Bioinformatics, 2013, 14(1): 13-26. [8] SHARMA A, IMOTO S, MIYANO S. A top-r feature selection algorithm for microarray gene expression data[J]. IEEE/ACM Transactions on Computational Biology and Bioinformatics (TCBB), 2012, 9(3): 754-764. [9] NANNI L, BRAHNAM S, LUMINI A. Combining multiple approaches for gene microarray classification[J]. Bioinformatics, 2012, 28(8): 1151-1157. [10] FAKOOR R, LADHAK F, NAZI A, ET AL. Using deep learning to enhance cancer diagnosis and classification[C]// Proceedings of the International Conference on Machine Learning, Atlanta, Georgia, USA, 2013. JMLR: W&CP, 2013, volume 28. [11] HUANG G B, ZHU Q Y, SIEW C K. Extreme learning machine: A new learning scheme of feedforward neural networks[C]// 2004 IEEE International Joint Conference on Neural Networks. IEEE, 2004, 2: 985-990. [12] HUANG G B, ZHU Q Y, SIEW C K. Extreme learning machine: Theory and applications[J]. Neurocomputing, 2006, 70(1): 489-501. [13] HUANG G B, CHEN L, SIEW C K. Universal approximation using incremental constructive feedforward networks with random hidden nodes[J]. IEEE Transactions on Neural Networks, 2006, 17(4): 879-892. [14] HUANG G B, BAI Z, KASUN LL C, et al. Local receptive fields based extreme learning machine[J]. IEEE Computational Intelligence Magazine, 2015, 10(2): 18-29. [15] KRIZHEVSKY A, SUTSKEVER I, HINTON G E. ImageNet classification with deep convolutional neural networks[C]// International Conference on Neural Information Processing Systems. Red Hook, NY: Curran Associates Inc, 2012:1097-1105. [16] SZEGEDY C, LIU W, JIAY, et al. Going deeper with convolutions[C]// 2015 IEEE Conference on Computer Vision and Pattern Recognition (CVPR). IEEE, 2015. [17] HE K, ZHANG X, REN S, et al. Deep residual learning for image recognition[C]// 2016 IEEE Conference on Computer Vision and Pattern Recognition. IEEE, 2016:770-778. [18] REN S, HE K, GIRSHICK R, et al. Faster R-CNN: Towards real-time object detection with region proposal networks[J]. IEEE Transactions on Pattern Analysis & Machine Intelligence, 2017, 39(6):1137-1149. [19] SCHERER D, MLLER A, BEHNKE S. Evaluation of pooling operations in convolutional architectures for object recognition[C]// International Conference on Artificial Neural Networks. Berlin/ Heidelberg: Springer-Verlag, 2010:92-101.
[20] MILLS K I, KOHLMANN A, WILLIAMS M, et al. Microarray classification of myelodysplastic syndrome (MDS) identifies subgroups with distinct clinical outcomes and identifies patients with high risk of AML transformation[J]. Blood, 2009(114): 1063-1072. [21] FUJIWARA T, HIRAMATSU M, ISAGAWA T, et al. ASCL1-coexpression profiling but not single gene expression profiling defines lung adenocarcinomas of neuroendocrine nature with poor prognosis[J]. Lung Cancer, 2012, 75(1): 119-125. [22] WOODWARD W A, KRISHNAMURTHY S, YAMAUCHI H, et al. Genomic and expression analysis of microdissected inflammatory breast cancer[J]. Breast Cancer Research & Treatment, 2013, 138(3): 761-772. [23] KLEIN H U, RUCKERT C, KOHLMANN A, et al. Quantitative comparison of microarray experiments with published leukemia related gene expression signatures[J]. BMC Bioinformatics, 2009, 10(1): 422. [24] Wl C M Y, PUI C H, DOWNING J R, et al. Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cells[J]. Nature Genetics, 2003, 34(1): 85-90. [25] YAGI T, MORIMOTO A, EGUCHI M, et al. Identification of a gene expression signature associated with pediatric AML prognosis[J]. Blood, 2003, 102(5): 1849. [26] GASHAW I, GRMMER R, KLEIN-HITPASS L, et al. Gene signatures of testicular seminoma with emphasis on expression of ets variant gene 4[J]. Cellular & Molecular Life Sciences Cmls, 2005, 62(19-20): 2359-2368. [27] PETRICOIN E F, ARDEKANI A M, HITT B A, et al. Use of proteomic patterns in serum to identify ovarian cancer[J]. Lancet, 2002, 359(9306): 572-577. [28] POMEROY S L, TAMAYO P, GAASENBEEK M, et al. Prediction of central nervous system embryonal tumour outcome based on gene expression[J]. Nature, 2002, 415(6870): 436. [29] SINGH D, FEBBO P G, ROSS K, et al. Gene expression correlates of clinical prostate cancer behavior[J]. Cancer Cell, 2002, 1(2): 203-209. [30] VERHAAK R G, WOUTERS B J, ERPELINCK C A, et al. Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling[J]. Haematologica, 2009, 94(1): 131-134. [31] ALON U, BARKAI N, NOTTERMAN D A, et al. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays[J]. Proceedings of the National Academy of Sciences of the United States of America, 1999, 96(12): 6745-6750.
() ( |